Gene-environment interactions in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 13, Issue SUPPL. 3, 2007, Pages

  Ross, Christopher A ^a   Smith, Wanli W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alpha Synuclein; Environmental factor; LRRK2; MPTP; Parkinson's disease model; Rotenone

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; DJ 1 PROTEIN; DOPAMINE RECEPTOR STIMULATING AGENT; EPOXOMICIN; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; PARAQUAT; PARKIN; PINK1 PROTEIN; PROTEIN DERIVATIVE; ROTENONE; TOXIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL FEATURE; DISEASE MODEL; ENVIRONMENT; ENVIRONMENTAL FACTOR; GENE; GENE INTERACTION; GENE MUTATION; GENETIC MODEL; HEREDITY; HUMAN; INVERTEBRATE; MEDICAL RESEARCH; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; DISEASE MODELS, ANIMAL; ENVIRONMENT; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; PARKINSON DISEASE; RISK FACTORS;

EID: 38949091068     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(08)70022-1     Document Type: Article

References (15)

1. Hardy J., Cai H., Cookson M., Gwinn-Hardy K., and Singleton A. Genetics of Parkinson's disease and parkinsonism. Ann Neurol 60 (2006) 389-398
2. Klein C., Lohmann-Hedrich K., Rogaeva E., Schlossmacher M., and Lang A. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 6 (2007) 652-662
3. Dick F. Parkinson's disease and pesticide exposures. Br Med Bull 79-80 (2006) 219-231
4. Ascherio A., Chen H., Weisskopf M., O'Reilly E., McCullough M., Calle E., et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 60 (2006) 197-203
5. Smith W., Jiang H., Pei Z., Tanaka Y., Morita H., Sawa A., et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet 14 (2005) 3801-3811
6. Smith W., Pei Z., Jiang H., Moore D., Liang Y., West A., et al. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci USA 102 (2005) 18676-18681
7. Smith W., Pei Z., Jiang H., Dawson V., and Dawson T. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9 (2006) 1231-1233
8. Cauchi R., and van den Heuvel M. The fly as a model for neurodegenerative diseases: is it worth the jump?. Neurodegener Dis 3 (2006) 338-356
9. Fleming S., and Chesselet M. Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism. Behav Pharmacol 17 (2006) 383-391
10. Manning-Bog A., and Langston J. Model fusion, the next phase in developing animal models for Parkinson's disease. Neurotox Res 11 (2007) 219-240
11. Li X., Tan Y., Poulose S., Olanow C., Huang X., and Yue Z. Leucine- rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J Neurochem (2007) in press.
12. MacLeod D., Dowman J., Hammond R., Leete T., Inoue K., and Abeliovich A. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52 (2006) 587-593
13. Melrose H., Lincoln S., Tyndall G., and Farrer M. Parkinson's disease: a rethink of rodent models. Exp Brain Res 173 (2006) 196-204
14. Tanaka Y., Engelender S., Igarashi S., Rao R., Wanner T., Tanzi R., et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria- dependent apoptosis. Hum Mol Genet 10 (2001) 919-926
15. 2-and Sin-1-induced cell death. Neurobiol Aging 28 (2007) 1709-1717